Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Lewy Body Dementia: early-phase trial registry
4 of 9 indexed Lewy Body Dementia trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,916 of 28,707 conditions by registered trial count.
9 US clinical trials · 4 currently recruiting · #1,916 of 28,707 conditions by registered trial count
Lewy Body Dementia: 9 US clinical trials tracked, 4 recruiting.
Lewy Body Dementia is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Axovant Sciences, running 1 of these trials.
Enrollment posture brief
Registry condition lewy-body-dementia
OPEN 4 | RECR 44% | LATE 0 | EARLY 1 | RANK #1916 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acute Ischemic Stroke (44% recruiting · 27 trials)
Lewy Body Dementia lists 4 open slots (44% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Lewy Body Dementia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Lewy Body Dementia is recruiting below its size-band peers.
4 of 9 indexed trials (44.4%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Lewy Body Dementia trials is spread across many organizations.
Axovant Sciences accounts for 1 of 9 trials (11.1%). 9 distinct sponsors appear on at least one study for this condition label.
-
Typical Lewy Body Dementia enrolment sits around 225 participants.
Median target enrolment is 225 among the 9 trials that report a genuine target (sentinel values excluded). 4 of those (44.4%) plan for fewer than 100 participants.
-
Lewy Body Dementia splits between interventional and observational designs.
5 interventional and 4 observational studies make up this index (55.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
9 total, page 1 of 1
Retinal Imaging in Neurodegenerative Disease
Duke University
NCT03233646
North American Prodromal Synucleinopathy Consortium Stage 2
Washington University School of Medicine
NCT05826457
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
Douglas Scharre
NCT03019757
Pulsed Electromagnetic Field Treatment With Dementia Patients
Herrick Medical
NCT06862557
PERSEVERE: Peer Mentor Support and Caregiver Education in Lewy Body Dementia
Rush University Medical Center
NCT06389032
A Study of Caregiver Connections Via Technology in Dementia
Mayo Clinic
NCT05779839
Environmental and Reproductive Health Risk for Lewy Body Dementia
University of California, San Diego
NCT06005935
Telehealth-enabled Integrated Palliative Care for People With Dementia
Thomas Jefferson University
NCT05524181
Study Evaluating Nelotanserin for Treatment of Visual Hallucinations in Subjects With Lewy Body Dementia
Axovant Sciences
NCT02640729
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Lewy Body Dementia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Lewy Body Dementia trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Lewy Body Dementia page
9 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Lewy Body Dementia trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Axovant Sciences sponsors the most Lewy Body Dementia trials on record, review their full trial history before evaluating a specific study. See Axovant Sciences's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Lewy Body Dementia condition card totals 9 registered trials; most-linked intervention Nelotanserin; top US site state Minnesota. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.